|
308240102
|
ANORO INH.PD.DOS (55+22)mcg/DOSE BTx 1 inhaler ELLIPTA (30 doses)
|
|
28,24 |
32,47 |
44,74 |
GlaxoSmithKline Trading Services Ltd
|
|
282100103
|
AVAMYS NASPR.SUS 27,5MC/ΨΕΚΑΣΜΟ 1 Φιάλη σε πλαστική συσκευή x 120 ψεκασμούς συσκευή x 120 ψεκασμούς
|
|
4,35 |
5,00 |
6,89 |
GlaxoSmithKline Trading Services Ltd
|
|
341700201
|
BLENREP PD.C.S.INF 100MG/VIAL BT X 1 VIAL
|
|
10.843,51 |
12.060,23 |
13.039,52 |
GlaxoSmithKline Trading Services Ltd
|
|
341700101
|
BLENREP PD.C.S.INF 70MG/VIAL BT X 1 VIAL
|
|
7.590,46 |
8.442,16 |
9.127,66 |
GlaxoSmithKline Trading Services Ltd
|
|
317820102
|
ELEBRATO ELLIPTA INH.PD.DOS (92+55+22)μg/DOSE BTx1 συσκευή εισπνοών (30 δόσεις)
|
|
40,04 |
46,03 |
63,43 |
GlaxoSmithKline Trading Services Ltd
|
|
307820102
|
INCRUSE INH.PD.DOS 55mcg/DOSE-UMECLIDINIUM (που ισοδυναμούν με UMECLIDIUNIUM BROMIDE 65mcg/DOSE) BTx1 συσκευή εισπνοών (Ellipta) x 30 δόσεις
|
|
16,97 |
19,51 |
26,88 |
GlaxoSmithKline Trading Services Ltd
|
|
327220101
|
JEMPERLI C/S.SOL.IN 500MG/VIAL 1 VIAL
|
|
4.323,59 |
4.808,73 |
5.199,19 |
GlaxoSmithKline Trading Services Ltd
|
|
308230102
|
LAVENTAIR INH.PD.DOS (55+22)mcg/DOSE BTx 1 inhaler ELLIPTA (30 doses)
|
|
28,24 |
32,47 |
44,74 |
GlaxoSmithKline Trading Services Ltd
|
|
313020203
|
NUCALA INJ.SOL 100MG/ML 1 προγεμισμένη σύριγγα
|
|
751,64 |
835,97 |
939,30 |
GlaxoSmithKline Trading Services Ltd
|
|
313020201
|
NUCALA INJ.SOL 100MG/ML 1 προγεμισμένη συσκευή τύπου πένας
|
|
751,41 |
835,72 |
939,01 |
GlaxoSmithKline Trading Services Ltd
|
|
313020301
|
NUCALA INJ.SOL 40MG/0,4ML 1 προγεμισμένη σύριγγα
|
|
341,10 |
379,37 |
442,35 |
GlaxoSmithKline Trading Services Ltd
|
|
313020101
|
NUCALA PD.INJ.SOL 100MG BTx1 VIAL
|
|
776,79 |
863,95 |
970,74 |
GlaxoSmithKline Trading Services Ltd
|
|
336410101
|
OMJJARA F.C.TAB 100MG/ΤΑΒ BT X 30 TABS ΣΕ BOTTLE (HDPE)
|
|
3.976,34 |
4.422,52 |
4.781,63 |
GlaxoSmithKline Trading Services Ltd
|
|
336410201
|
OMJJARA F.C.TAB 150MG/ΤΑΒ BT X 30 TABS ΣΕ BOTTLE (HDPE)
|
|
3.976,34 |
4.422,52 |
4.781,63 |
GlaxoSmithKline Trading Services Ltd
|
|
336410301
|
OMJJARA F.C.TAB 200MG/ΤΑΒ BT X 30 TABS ΣΕ BOTTLE (HDPE)
|
|
3.976,34 |
4.422,52 |
4.781,63 |
GlaxoSmithKline Trading Services Ltd
|
|
306540202
|
RELVAR ELLIPTA INH.PD.DOS (184+22)mcg/DOSE BTx1 συσκευή εισπνοών x30 δόσεις συσκευή εισπνοών x30 δόσεις
|
|
22,64 |
26,03 |
35,87 |
GlaxoSmithKline Trading Services Ltd
|
|
306540102
|
RELVAR ELLIPTA INH.PD.DOS (92+22)mcg/DOSE BTx1 συσκευή εισπνοών x30 δόσεις συσκευή εισπνοών x30 δόσεις
|
|
19,68 |
22,62 |
31,17 |
GlaxoSmithKline Trading Services Ltd
|
|
307860202
|
REVINTY ELLIPTA INH.PD.DOS (184+22)mcg/DOSE 1 συσκευή εισπνοών x30 δόσεις
|
|
22,64 |
26,03 |
35,87 |
GlaxoSmithKline Trading Services Ltd
|
|
307860102
|
REVINTY ELLIPTA INH.PD.DOS (92+22)mcg/DOSE 1 συσκευή εισπνοών x30 δόσεις
|
|
19,68 |
22,62 |
31,17 |
GlaxoSmithKline Trading Services Ltd
|
|
316400102
|
ROLUFTA INH.PD.DOS 55MCG/DOSE BTx1 συσκευή εισπνοών ELLIPTA σε BLISTER (alu) x 30 δόσεις
|
|
18,19 |
20,91 |
28,81 |
GlaxoSmithKline Trading Services Ltd
|
|
317810102
|
TRELEGY ELLIPTA INH.PD.DOS (92+55+22)μg/DOSE BTx1 συσκευή εισπνοών (30 δόσεις)
|
|
38,84 |
44,64 |
61,51 |
GlaxoSmithKline Trading Services Ltd
|
|
242220101
|
ZEFFIX F.C.TAB 100MG/TAB BTX28(BLISTERS)
|
|
17,32 |
19,90 |
27,42 |
GlaxoSmithKline Trading Services Ltd
|
|
242220201
|
ZEFFIX ORAL.SOL 5MG/ML FLX240ML
|
|
8,48 |
9,75 |
13,44 |
GlaxoSmithKline Trading Services Ltd
|
|
322280203
|
ZEJULA F.C.TAB 100MG/TAB 56 ΔΙΣΚΙΑ ΣΕ ΚΥΨΕΛΗ (OPA/AL/PVC/AL/VINYL/ACRYLIC/PAPER)
|
|
2.918,78 |
3.246,28 |
3.509,88 |
GlaxoSmithKline Trading Services Ltd
|
|
322280201
|
ZEJULA F.C.TAB 100MG/TAB 56 Χ 1 ΔΙΣΚΙΑ (ΜΙΑΣ ΔΟΣΗΣ) ΣΕ ΚΥΨΕΛΗ (OPA/AL/PVC/AL/VINYL/ACRYLIC)
|
|
2.918,78 |
3.246,28 |
3.509,88 |
GlaxoSmithKline Trading Services Ltd
|
